Medis Suite MR
Medis Medical ImagingProduct specifications |
Information source:
Vendor
Last updated: Sept. 16, 2021 |
General | |
---|---|
Product name | Medis Suite MR |
Company | Medis Medical Imaging |
Subspeciality | Cardiac |
Modality | MR |
Disease targeted | Heart failure, ischemic heart disease, myocardial infarction, cardiomyopathies, myocarditis, valvular heart disease, cardiac mass, pericardial disease, atrial fibrillation, congenital heart disease |
Key-features | Volume quantification, strain quantification, function assessment, flow quantification, infarct quantification and segmentation, T1 mapping, T2 Mapping, ECV mapping, perfusion assessment, 4D flow visualization |
Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion |
Data characteristics | |
Population | All cardiac MR scan |
Input | Cardiac MR from 1.5T and 3.0T machines |
Input format | DICOM |
Output | Table of quantified values, normal values, bull's eye plots, draft report, snapshot of images |
Output format | DICOM Secondary Capture (single-frame), DICOM Secondary Capture (multi-frame), DICOM PDF, DICOM SR, XML, Json |
Technology | |
Integration | Integration RIS (Radiological Information System), Stand-alone third party application |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker) |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 1994 |
Distribution channels | Direct sales and distribution partners |
Countries present (clinical, non-research use) | The Netherlands (HQ), Germany, United Kingdom, USA, Japan, France, Spain, Portugal, Italy, Poland, Iran, Mexico, Cono Sur, Middle East, India, Iran, South East Asia, Australia, New Zealand, China, South Korea |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Subscription, One-off payment |
Based on | Number of users |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |